← Back to All Filings

UnitedHealth Group Director Scott Gottlieb Awarded Quarterly Stock Grant

Low SignificanceOctober 5, 2026 at 5:08:52 PM EDT

UNITEDHEALTH GROUP INC

$UNH4CIK: 0000731766

Subscribe to track UNH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

UnitedHealth Group Inc ($UNH) Form 4 Filing Update

Insider: Scott Gottlieb (Director) Transaction Date: 2026-10-01 Type: Acquisition (Award/Grant) Amount: 257 shares @ $0.00 Value: $0.00 Shares Held After: 921 Significance: Low (Routine quarterly director compensation)

Comprehensive Analysis

Executive Summary

On October 1, 2026, UnitedHealth Group Inc (NYSE: UNH) director Scott Gottlieb acquired 257 shares of Common Stock in the form of deferred stock units (DSUs) at $0 per share. The transaction was reported to the SEC on Form 4 on October 5, 2026.

Transaction Details

  • Security: Common Stock (Deferred Stock Units)
  • Transaction Code: A (Grant/Award)
  • Shares Acquired: 257
  • Price per Share: $0.00
  • Post-Transaction Holdings: 921 shares
  • Ownership Nature: Direct

Context & Significance

This transaction represents regular quarterly equity compensation for service on the Board of Directors of UnitedHealth Group. According to the filing footnotes, the deferred stock units are immediately vested but must be retained until the director completes their service on the Board. Because this is a standard non-market equity award under the company's director compensation program rather than an open-market purchase or sale, the trading significance is categorized as Low.

Topics:#UNH#UnitedHealth#InsiderTrading#SECForm4#Healthcare

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.